Subcutaneous implantable cardioverter-defibrillator screening ECG during exercise in patients vulnerable for T-wave oversensing

Withdrawn

• Conditions: heart rhythm disturbances; 10007521; 10007510

• Registration Number: NL-OMON38930
• Lead Sponsor: Academisch Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 29 April 2024

Recruitment & Eligibility

• Status: Withdrawn
• Sex: Not specified
• Target Recruitment: 100

Inclusion Criteria

Young patients <40 yrs, patients with inherited arrhythmogenic syndromes (Brugada syndrome, long QT syndrome, catecholaminergic polymorphic ventricular tachycardia, hypertrophic cardiomyopathy and idiopathic VF, such as carriers of the DPP6 haplotype), patients with a QRS duration between 100 and 150ms on baseline ECG, patients with large T-waves on baseline ECG and other patients vulnerable for T-wave oversensing according to the literature

Exclusion Criteria

Younger than 18 years

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Baseline demographics and ECG characteristics of patients with an unacceptable<br /><br>QRS/T-morphology recorded with a special type of ECG during an exercise test<br /><br>are compared to patients with an acceptable QRS/T-morphology. </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>None</p><br>